Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2

American Journal of Pathology

Volumn 177, Issue 6, 2010, Pages 3025-3036

  Raheem, Olayinka ^a   Olufemi, Shodimu Emmanuel ^b   Bachinski, Linda L ^b   Vihola, Anna ^c   Sirito, Mario ^b   Holmlund Hampf, Jeanette ^c   Haapasalo, Hannu ^d   Li, Yi Ping ^e   Udd, Bjarne ^a,c,f   Krahe, Ralf ^b,g  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

^d PIRKANMAA HOSPITAL DISTRICT   (Finland)

^e FORSYTH INSTITUTE   (United States)

^f VAASA CENTRAL HOSPITAL   (Finland)

^g UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 9;

ADULT; AGED; ALLELE; ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTRON; MALE; MUSCLE CELL; MYOBLAST; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY TYPE 1; MYOTONIC DYSTROPHY TYPE 2; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SARCOMERE; SPLICING DEFECT;

EID: 78650188780     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100179     Document Type: Article

References (36)

1. Harper PS: Myotonic Dystrophy. London, Saunders, 1989, pp 1-384
2. Udd B, Meola G, Krahe R, Thornton C, Ranum LP, Bassez G, Kress W, Schoser B, Moxley R: 140th ENMC International Workshop: myotonic dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management. Neuromuscul Disord 2006, 16:403-413 (Pubitemid 43884790)
3. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T: Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992, 68:799-808
4. Fu YH, Pizzuti A, Fenwick RG, Jr, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P: An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992, 255:1256-1258
5. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barcelo J, O'Hoy K: Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 1992, 255:1253-1255
6. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP: Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001, 293:864-867
7. Bachinski LL, Udd B, Meola G, Sansone V, Bassez G, Eymard B, Thornton CA, Moxley RT, Harper PS, Rogers MT, Jurkat-Rott K, Lehmann-Horn F, Wieser T, Gamez J, Navarro C, Bottani A, Kohler A, Shriver MD, Sallinen R, Wessman M, Zhang S, Wright FA, Krahe R: Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am J Hum Genet 2003, 73:835-848
8. Bachinski LL, Czernuszewicz T, Ramagli LS, Suominen T, Shriver MD, Udd B, Siciliano MJ, Krahe R: Premutation allele pool in myotonic dystrophy type 2. Neurology 2009, 72:490-497
9. Udd B, Krahe R, Wallgren-Pettersson C, Falck B, Kalimo H: Proximal myotonic dystrophy: a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism; heterogeneity of proximal myotonic syndromes? Neuromuscul Disord 1997, 7:217-228
10. Udd B, Meola G, Krahe R, Thornton C, Ranum L, Day J, Bassez G, Ricker K: Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies; 3rd Workshop, 14-16 February 2003; Naarden, The Netherlands. Neuromuscul Disord 2003, 13:589-596
11. Vihola A, Bassez G, Meola G, Zhang S, Haapasalo H, Paetau A, Mancinelli E, Rouche A, Hogrel JY, Laforet P, Maisonobe T, Pellissier JF, Krahe R, Eymard B, Udd B: Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 2003, 60:1854-1857
12. Schoser BG, Schneider-Gold C, Kress W, Goebel HH, Reilich P, Koch MC, Pongratz DE, Toyka KV, Lochmuller H, Ricker K: Muscle pathology in 57 patients with myotonic dystrophy type 2. Muscle Nerve 2004, 29:275-281 (Pubitemid 38166851)
13. Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, Lin L, Roberts R, Caskey CT, Swanson MS: Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res 1996, 24:4407-4414 (Pubitemid 26388627)
14. Osborne RJ, Thornton CA: RNA-dominant diseases. Hum Mol Genet 2006, 15 Spec No 2:R162-R169
15. Ho TH, Savkur RS, Poulos MG, Mancini MA, Swanson MS, Cooper TA: Colocalization of muscleblind with RNA foci is separable from misregulation of alternative splicing in myotonic dystrophy. J Cell Sci 2005, 118:2923-2933
16. Wang J, Pegoraro E, Menegazzo E, Gennarelli M, Hoop RC, Angelini C, Hoffman EP: Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum Mol Genet 1995, 4:599-606
17. Botta A, Caldarola S, Vallo L, Bonifazi E, Fruci D, Gullotta F, Massa R, Novelli G, Loreni F: Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2). Biochim Biophys Acta 2006, 1762:329-334
18. Margolis JM, Schoser BG, Moseley ML, Day JW, Ranum LP: DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression. Hum Mol Genet 2006, 15:1808-1815
19. Chen W, Wang Y, Abe Y, Cheney L, Udd B, Li YP: Haploinsuffciency for Znf9 in Znf9+/- mice is associated with multiorgan abnormalities resembling myotonic dystrophy. J Mol Biol 2007, 368:8-17
20. Gerbasi VR, Link AJ: The myotonic dystrophy type 2 protein ZNF9 is part of an ITAF complex that promotes cap-independent translation. Mol Cell Proteomics 2007, 6:1049-1058
21. Salisbury E, Schoser B, Schneider-Gold C, Wang GL, Huichalaf C, Jin B, Sirito M, Sarkar P, Krahe R, Timchenko NA, Timchenko LT: Expression of RNA CCUG repeats dysregulates translation and degradation of proteins in myotonic dystrophy 2 patients. Am J Pathol 2009, 175:748-762
22. Huichalaf C, Schoser B, Schneider-Gold C, Jin B, Sarkar P, Timchenko L: Reduction of the rate of protein translation in patients with myotonic dystrophy 2. J Neurosci 2009, 29:9042-9049
23. Sallinen R, Vihola A, Bachinski LL, Huoponen K, Haapasalo H, Hackman P, Zhang S, Sirito M, Kalimo H, Meola G, Horelli-Kuitunen N, Wessman M, Krahe R, Udd B: New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2). Neuromuscul Disord 2004, 14:274-283
24. Vihola A, Bachinski LL, Sirito M, Olufemi SE, Hajibashi S, Baggerly KA, Raheem O, Haapasalo H, Suominen T, Holmlund-Hampf J, Paetau A, Cardani R, Meola G, Kalimo H, Edstrom L, Krahe R, Udd B: Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2. Acta Neuropathol 2010, 119:465-479
25. Krahe R, Ashizawa T, Abbruzzese C, Roeder E, Carango P, Giacanelli M, Funanage VL, Siciliano MJ: Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics 1995, 28:1-14
26. Haravuori H, Vihola A, Straub V, Auranen M, Richard I, Marchand S, Voit T, Labeit S, Somer H, Peltonen L, Beckmann JS, Udd B: Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene. Neurology 2001, 56:869-877
27. Chen W, Liang Y, Deng W, Shimizu K, Ashique AM, Li E, Li YP: The zinc-finger protein CNBP is required for forebrain formation in the mouse. Development 2003, 130:1367-1379 (Pubitemid 36410784)
28. Reddy S, Smith DB, Rich MM, Leferovich JM, Reilly P, Davis BM, Tran K, Rayburn H, Bronson R, Cros D, Balice-Gordon RJ, Housman D: Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet 1996, 13:325-335
29. Brogna S, Wen J: Nonsense-mediated mRNA decay (NMD) mechanisms. Nat Struct Mol Biol 2009, 16:107-113
30. Pelletier R, Hamel F, Beaulieu D, Patry L, Haineault C, Tarnopolsky M, Schoser B, Puymirat J: Absence of a differentiation defect in muscle satellite cells from DM2 patients. Neurobiol Dis 2009, 36:181-190
31. Rajavashisth TB, Taylor AK, Andalibi A, Svenson KL, Lusis AJ: Identification of a zinc finger protein that binds to the sterol regulatory element. Science 1989, 245:640-643 (Pubitemid 19213341)
32. Warden CH, Krisans SK, Purcell-Huynh D, Leete LM, Daluiski A, Diep A, Taylor BA, Lusis AJ: Mouse cellular nucleic acid binding proteins: a highly conserved family identified by genetic mapping and sequencing. Genomics 1994, 24:14-19
33. Yasuda J, Mashiyama S, Makino R, Ohyama S, Sekiya T, Hayashi K: Cloning and characterization of rat cellular nucleic acid binding protein (CNBP) cDNA. DNA Res 1995, 2:45-49
34. Flink IL, Morkin E: Alternatively processed isoforms of cellular nucleic acid-binding protein interact with a suppressor region of the human beta-myosin heavy chain gene. J Biol Chem 1995, 270:6959-6965
35. Pellizzoni L, Lotti F, Maras B, Pierandrei-Amaldi P: Cellular nucleic acid binding protein binds a conserved region of the 5′ UTR of Xenopus laevis ribosomal protein mRNAs. J Mol Biol 1997, 267:264-275
36. Massa R, Panico MB, Caldarola S, Fusco FR, Sabatelli P, Terracciano C, Botta A, Novelli G, Bernardi G, Loreni F: The myotonic dystrophy type 2 (DM2) gene product zinc finger protein 9 (ZNF9) is associated with sarcomeres and normally localized in DM2 patients' muscles. Neuropathol Appl Neurobiol 2010, 36:275-284